Overview

Gender

male

David Amerson is the President & Chief Executive Officer at Neo Tract.

Dave joined NeoTract in July 2011 as President and CEO. He brings over 25 years of management experience in the medical device field with an emphasis in urology.

Most recently, Dave served as Global Vice President, General Manager for the Coloplast Surgical Urology division and was Chairman of the Surgical Urology Leadership Team. In these roles, he was responsible for Sales, Marketing, Quality/Regulatory, R&D, Clinical Studies, Manufacturing and Legal.

In 2006, Dave was the point person for the divestiture of Mentor’s urology business unit that was acquired by Coloplast Corporation for $463M. Post-acquisition, Dave led the Global Surgical Urology division at Coloplast to achieve double digit sales growth and launch several innovative new products.

Dave began his career at Osbon Medical Systems where he built a successful sales and marketing team that achieved aggressive sales growth.

Osbon Medical was acquired by Urohealth Systems, Inc. in 1995 for $44M. Dave is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics.

Dave holds an M.B.A. from Argosy University.

B.A. in Political Science from the University of West Georgia.